Active ingredientLafutidineCat. No. P-L007-001CAS 118288-08-7Family · Pharmaceutical analytical standards
Lafutidine
A histamine H2 receptor antagonist developed in Japan and in use since the early 2000s: it reduces stomach acidity and is used for gastric and duodenal ulcer and gastritis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Besides reducing acid, it protects the stomach lining through capsaicin-sensitive nerve fibres, capsaicin being the very molecule that makes chilli peppers hot.
Go to the active ingredient →Active ingredientLafutidineCat. No. P-L007-001CAS 118288-08-7
Isotopically labelledLafutidine-d10Cat. No. P-L007-002CAS 1795136-26-3
ImpurityLafutidine Impurity 1Cat. No. P-L007-004CAS 169899-16-5
ImpurityLafutidine Impurity 2Cat. No. P-L007-005CAS 169899-15-4
ImpurityLafutidine Impurity 3Cat. No. P-L007-006CAS 103922-84-5
Impurity4-Aminobut-2-en-1-olCat. No. P-L007-007CAS 41372-34-3
Impuritycis-4-Chloro-2-butenylamine hydrochlorideCat. No. P-L007-008CAS 7153-66-4
ImpurityLafutidine Acetate Ester ImpurityCat. No. P-L007-009CAS 123855-55-0
ImpurityLafutidine Dihydro ImpurityCat. No. P-L007-010CAS 118288-14-5
ImpurityLafutidine Impurity 4Cat. No. P-L007-011CAS 154923-16-7
ImpurityLafutidine Impurity 5Cat. No. P-L007-012CAS 1348637-58-0
ImpurityLafutidine Impurity 6Cat. No. P-L007-013CAS 1819326-30-1
ImpurityLafutidine Impurity 7 MaleateCat. No. P-L007-014CAS 146447-26-9
ImpurityLafutidine Impurity 8Cat. No. P-L007-015CAS 1339863-11-4
ImpurityLafutidine N-OxideCat. No. P-L007-018CAS 169899-18-7
ImpurityLafutidine SulfoneCat. No. P-L007-019CAS 174583-84-7
ImpurityLafutidine Impurity 9Cat. No. P-L007-020CAS 169899-17-6
ImpurityRacemic trans-LafutidineCat. No. P-L007-021CAS 206449-94-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.